CoreAge Rx vs WellMedr
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and WellMedr head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 53 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make WellMedr a bad call — it's best for readers who already intend to commit to a full year and want to know exactly what the $59 does and does not include before they do — and readers shopping the microdose line, which is a real eight-product range here rather than a smaller amount of a standard plan. not readers trying to price a single month they can walk away from. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | WellMedr |
|---|---|---|
| Brief Score | 94/100 (A) | 53/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Not disclosed — the advertised rate is tied to a 12-month plan and no month-to-month price is published |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Not disclosed — no month-to-month price is published; plans bill every 4 weeks |
| Coverage | US only; restrictions by state, confirmed at intake | Coverage not published |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
WellMedr: The $59 semaglutide headline is tied to a twelve-month plan; the term behind the $99 tirzepatide headline needs confirmation. Both plans ship every four weeks, so compare the full charge and supply period before paying.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.